Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using anIn VivoMurine Invasive Candidiasis Model
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.04445-14
Full Text
Open PDFAbstract
Available in full text
Date
December 15, 2014
Authors
Publisher
American Society for Microbiology